ETF & Derivatives Trader
About the job
- Prior experience in capital markets, equity trading, derivatives, quantitative trading, or a related client-facing or institutional role.
- A bachelor's degree in engineering, mathematics, computer science, or a related technical field is preferred.
- Strong commercial instincts, communication skills, and a practical understanding of equity markets and listed derivatives.
- Strong understanding of ETF ecosystem dynamics, including authorized participants, creation and redemption processes, and market structure.
- Experience trading derivative instruments, including futures, options, swaps, and foreign exchange products.
- Strong knowledge of capital markets, portfolio management principles, and risk management practices.
- Advanced proficiency in Excel and market or trading platforms such as Bloomberg, Fidessa, IRESS, WEX, or equivalent systems.
- Strong analytical, quantitative, and problem-solving skills.
- Strong attention to detail and ability to operate effectively in a fast-paced environment.
- Facilitate institutional client orders across ETFs, equity index and single-stock futures, and equity options.
- Quote competitive markets, provide liquidity in Canadian-listed ETFs, and manage inventory risk.
- Identify and pursue quantitative trading strategies within equity markets.
- Deliver market colour, trade ideas, and execution to clients.
- Build and enhance internal tools that support pricing, risk management, execution, and client service.
About the company
Canaccord Genuity Group is a global, full-service investment bank that offers advisory, capital markets, and wealth-management services to corporate, institutional, and individual clients. It works by connecting clients with capital markets and financial solutions, handling underwriting, financing, M&A advisory, research, and trading through a global platform. The company differentiates itself by providing a wide range of services under one firm across multiple regions, rather than relying on separate specialists. Its goal is to help clients grow their businesses and manage wealth by navigating capital markets and financial strategies worldwide.
Company Size
501-1,000
Company Stage
IPO
Headquarters
Toronto, Canada
Founded
1950
Get referred to Canaccord Genuity Group
See people who can refer or advise you
Simplify's Take
What believers are saying
- June 2026 results delivered $2.2 billion revenue, 24.9% growth, and higher dividends.
- August 2026 acquisition of EFG Harris Allday adds £3.1 billion assets and affluent clients.
- January 2026 CRC-IB acquisition expands energy-transition advisory into renewables project finance.
What critics are saying
- FinCEN's March 2026 $80 million penalty exposed systemic AML failures and fraud exposure.
- UK wealth sale talks signal strategic uncertainty and possible 2027 execution risk.
- Canaccord's U.S. OTC market making is gone, shrinking diversification and recurring trading revenue.
What makes Canaccord Genuity Group unique
- Canada-to-UK-Australia platform with record fiscal 2026 revenue and 472 transactions.
- Sell-side and ECM strength, with U.S. advisory, research, and private placement capabilities.
- Wealth and capital markets integration deepens client retention across middle-market and affluent channels.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Hybrid Work Options
Company News
Stardust Metal Corp. has closed a brokered private placement offering, raising approximately $14.5 million in gross proceeds. The Toronto-based company, trading as TSXV: ZIGY, completed the financing with Canaccord Genuity Corp. as lead agent and sole bookrunner, alongside a syndicate including Velocity Trade Capital Ltd., CIBC World Markets Inc., and Clarus Securities Inc. The offering comprised 3,847,000 premium flow-through common shares at $2.725 each, generating roughly $10.5 million, and 2,051,000 common shares at $1.95 each, raising approximately $4 million. The company paid agents a 6% cash commission totalling $450,978. A strategic investor acquired 2,556,410 common shares, representing about 5% of outstanding shares, and entered into an investor rights agreement allowing participation in future equity financings.
Viking Therapeutics has priced an upsized $500 million concurrent public offering of common stock and convertible senior notes. The clinical-stage biopharmaceutical company will sell 7,857,143 shares at $35.00 per share and $225 million in 2% convertible senior notes due 2032. The offering size was increased from the previously announced $200 million for each component. The notes carry an initial conversion price of approximately $50.75 per share, representing a 45% premium over the public offering price. Viking estimates net proceeds of approximately $258.2 million from the common stock offering and $218 million from the note offering, after deducting underwriting discounts and expenses. The company intends to use proceeds for continued clinical development of its VK2735 and VK3019 programmes, as well as general research and development purposes. Morgan Stanley, JPMorgan, Jefferies, Leerink Partners, and William Blair are serving as joint book-running managers.
CD&R, Warburg Pincus in talks to buy Canaccord's UK wealth arm - report. According to sources cited by Reuters in October 2025, the business could be worth more than £1bn ($1.34bn). CD&R and Warburg Pincus are discussing a possible acquisition of Canaccord Wealth, the UK wealth business of Canaccord Genuity, reported Reuters citing sources. The two private equity firms are said to be in advanced talks on a joint bid, after becoming one of the frontrunners in a sale process that began last year, the sources said. According to sources cited by Reuters in October 2025, the business could be worth more than £1bn ($1.34bn). Representatives for CD&R and Warburg Pincus declined to comment. Canaccord Genuity and Canaccord Wealth did not immediately reply to requests for comment. An independent investment bank Fenchurch has been advising Canaccord Genuity on the disposal, sources had earlier told the news agency. The earlier report said BlackRock-owned private credit group HPS, which has owned a minority holding in Canaccord Wealth since 2021, was expected to sell its stake as part of any transaction. Canaccord Wealth offers investment management, financial planning and wealth advisory services to private clients in the UK and overseas. The UK wealth management and financial advice sector has seen a series of transactions in recent years as companies pursue larger scale and seek to benefit from increasing demand for wealth services. NatWest Group earlier this year agreed a £2.7bn ($3.6bn) deal for Evelyn Partners. Earlier this year, Nuveen reached an agreement to take Schroders private for about £9.9bn ($13.5bn), covering the entire issued and to-be-issued share capital of the British asset management company. In 2023, Rathbones Group and Investec had agreed to an all-share combination. Give your business an edge with its leading industry insights.
Warburg Pincus and CD&R near deal to buy Canaccord's UK wealth division. Save over 40% on standard digital. $540 $299 for your first year. Save now on essential digital access to trusted FT journalism on any device. Savings based on annualised monthly price.
Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, Sept. 20, 2026 (GLOBE NEWSWIRE)